Literature DB >> 15194460

Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1.

Thomas G von Lueder1, Harald Kjekshus, Thor Edvardsen, Erik ØIe, Stig Urheim, Leif Erik Vinge, Muhammed Shakil Ahmed, Otto A Smiseth, Håvard Attramadal.   

Abstract

OBJECTIVE: The pulmonary circulation may contribute to elevated plasma levels of endothelin-1 (ET-1) in congestive heart failure (CHF). The aims of the present study were to determine the mechanisms of increased secretion of ET-1 from the pulmonary circulation in CHF.
METHODS: Juvenile pigs were subjected to sham operation (n=9) or rapid cardiac pacing-induced CHF (215-240 bpm, n=15).
RESULTS: Three weeks of rapid pacing led to significant left ventricular dilatation, increased cardiac filling pressures, and reduced contractility (CHF pigs). Arterial plasma ET-1 levels in the CHF pigs were increased 4-fold compared to sham pigs (P<0.001). Single-bolus multiple indicator-dilution experiments revealed that pulmonary synthesis and release of ET-1 was increased in CHF, while pulmonary clearance of plasma ET-1 remained unaltered despite significant reduction of pulmonary fractional extraction of plasma ET-1. Pulmonary ECE-1 isozyme activity (pmol.min-1.mg protein-1) was selectively increased in lower lobe segments of CHF pigs (2.0+/-0.3) compared to lower lobe segments of controls (1.1+/-0.1, P<0.02), and to upper lobe segments of CHF pigs (1.1+/-0.1, P<0.005), and correlated significantly with the wet/dry weight ratios of the pulmonary tissue samples (R=0.75, P<0.001), i.e. a marker of pulmonary congestion. Furthermore, alveolar macrophages in congested lobe segments were identified as likely sites of increased synthesis and release of ET-1.
CONCLUSIONS: In rapid pacing-induced CHF, a complex cardiopulmonary interaction revealed by pulmonary congestion causes increased pulmonary production and secretion of ET-1 due to enhanced pulmonary ECE-1 activities. Pulmonary secretion of ET-1 during evolving CHF is an important contributor to elevated plasma ET-1 levels in the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194460     DOI: 10.1016/j.cardiores.2004.03.016

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  Role of endothelin receptor activation in secondary pulmonary hypertension in awake swine after myocardial infarction.

Authors:  Birgit Houweling; Daphne Merkus; Oana Sorop; Frans Boomsma; Dirk J Duncker
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

2.  Alterations in endothelial control of the pulmonary circulation in exercising swine with secondary pulmonary hypertension after myocardial infarction.

Authors:  Daphne Merkus; Birgit Houweling; Vincent J de Beer; Zaida Everon; Dirk J Duncker
Journal:  J Physiol       Date:  2007-02-08       Impact factor: 5.182

3.  Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease.

Authors:  Herbert B Tanowitz; Huan Huang; Linda A Jelicks; Madhulika Chandra; Maria L Loredo; Louis M Weiss; Stephen M Factor; Vitaliy Shtutin; Shankar Mukherjee; Richard N Kitsis; George J Christ; Murray Wittner; Jamshid Shirani; Yaz Y Kisanuki; Masashi Yanagisawa
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 4.  Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.

Authors:  Thomas G von Lueder; S Jeson Sangaralingham; Bing H Wang; Andrew R Kompa; Dan Atar; John C Burnett; Henry Krum
Journal:  Circ Heart Fail       Date:  2013-05       Impact factor: 8.790

Review 5.  [Renal dysfunction in heart failure and hypervolumenia : Importance of congestion and backward failure].

Authors:  W Druml
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-05-10       Impact factor: 0.840

Review 6.  Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.

Authors:  Zaid Abassi; Ilia Goltsman; Tony Karram; Joseph Winaver; Aaron Hoffman
Journal:  J Biomed Biotechnol       Date:  2011-01-11

7.  Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure.

Authors:  Liv I Bjoner Sikkeland; Christen P Dahl; Thor Ueland; Arne K Andreassen; Einar Gude; Thor Edvardsen; Torbjørn Holm; Arne Yndestad; Lars Gullestad; Johny Kongerud; Pål Aukrust; Erik Øie
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

8.  Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque.

Authors:  Violeta J Rodriguez; John M Abbamonte; Manasi S Parrish; Deborah L Jones; Stephen Weiss; Suresh Pallikkuth; Michal Toborek; Maria L Alcaide; Dushyantha Jayaweera; Savita Pahwa; Tatjana Rundek; Barry E Hurwitz; Mahendra Kumar
Journal:  Int J STD AIDS       Date:  2021-11-02       Impact factor: 1.456

Review 9.  Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.

Authors:  Shihui Fu; Ping Ping; Fengqi Wang; Leiming Luo
Journal:  J Biol Eng       Date:  2018-01-12       Impact factor: 4.355

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.